Depo-Provera(These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959)

Pharmacia & Upjohn Company LLC🇺🇸 United States

FDA Page

Effective Date: Dec 31, 2020
Approval ID: 199cf13e-0859-4a73-9b45-e700d0cd1049
Products: 2 registered
Version: 25

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959

Quick Stats

Total Products2

Labelers2

Label Sections23

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.